Navigation Links
PNAS announces 2007 Cozzarelli Prize recipients
Date:2/13/2008

WASHINGTON The editors of the Proceedings of the National Academy of Sciences (PNAS) have selected six outstanding PNAS papers for the 2007 Cozzarelli Prize, an award for papers that reflect the highest standards of scientific excellence and originality.

The award was established in 2005 as the PNAS Paper of the Year Prize and renamed the Cozzarelli Prize in 2007 to honor late PNAS Editor-in-Chief Nicholas R. Cozzarelli. The annual award acknowledges papers published in PNAS during the previous year that reflect exceptional contributions to the scientific disciplines represented by the National Academy of Sciences. The 2007 awards will be presented at the PNAS Editorial Board Meeting on April 27, 2008, in Washington, DC.

Papers receiving the Cozzarelli Prize were chosen from more than 3,600 research articles published by PNAS in 2007 and represent the six broadly defined classes under which the National Academy of Sciences is organized.

2007 Cozzarelli Prize Recipients

Class I (Physical and Mathematical Sciences)

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
by Tommy Cedervall, Iseult Lynch, Stina Lindman, Tord Berggard, Eva Thulin, Hanna Nilsson, Kenneth A. Dawson, and Sara Linse
http://www.pnas.org/cgi/doi/10.1073/pnas.0608582104

A commentary accompanying this article is available:
http://www.pnas.org/cgi/content/extract/104/7/2029

Class II (Biological Sciences)

Muller cells are living optical fibers in the vertebrate retina
by Kristian Franze, Jens Grosche, Serguei N. Skatchkov, Stefan Schinkinger, Christian Foja, Detlev Schild, Ortrud Uckermann, Kort Travis, Andreas Reichenbach, and Jochen Guck
http://www.pnas.org/cgi/content/full/104/20/8287

Class III (Engineering and Applied Sciences)

Faceting ionic shells into icosahedra via electrostatics
by Graziano Vernizzi and Monica Olvera de la Cruz
http://www.pnas.org/cgi/content/full/104/47/18382

Class IV (Biomedical Sciences)

Targeted Delivery of Proteins across the Blood-Brain Barrier
by Brian J. Spencer and Inder M. Verma
http://www.pnas.org/cgi/doi/10.1073/pnas.0702170104

A commentary accompanying this article is available:
http://www.pnas.org/cgi/content/full/104/18/7315

Class V (Behavioral and Social Sciences)

Savanna chimpanzees use tools to harvest the underground storage organs of plants
by R. Adriana Hernandez-Aguilar, Jim Moore, and Travis Rayne Pickering
http://www.pnas.org/cgi/content/full/104/49/19210

A commentary accompanying this article is available:
http://www.pnas.org/cgi/content/full/104/49/19167</p>

Class VI (Applied Biological, Agricultural, and Environmental Sciences)

Incorporating plant functional diversity effects in ecosystem service assessments
by Sandra Diaz, Sandra Lavorel, Francesco de Bello, Fabien Quetier, Karl Grigulis, and T. Matthew Robson
http://www.pnas.org/cgi/content/full/104/52/20684

This article was cited in the PNAS Land Change Science Special Feature:
http://www.pnas.org/cgi/content/full/104/52/20666


'/>"/>

Contact: Jonathan Lifland
pnasnews@nas.edu
202-334-1310
Proceedings of the National Academy of Sciences (PNAS)
Source:Eurekalert

Related medicine news :

1. Microsoft Announces the Amalga Family of Health Enterprise Systems
2. Elsevier Foundation announces grants for innovative libraries and new scholars
3. Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars
4. Echo Therapeutics Announces Closing of Approximately $2.3 Million Private Financing
5. Transition Therapeutics Announces Second Quarter Fiscal 2008 Financial Results
6. XTENT Announces 2007 Financial Results Conference Call
7. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
8. USHEALTH Group Announces Appointment of Executive Vice President
9. Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
10. Herley Industries Announces the Passing of Its Former President
11. GPhA Announces 2008-2009 Executive Committee; Teva North Americas Bill Marth Elected as Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... CA (PRWEB) , ... January 24, 2017 , ... Learn ... studies, work, athletics or even in relationships. Course offered by Dr. Carol Francis ... necessary due to limited seating and the many hands-on experiences. , Dr. ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... advocacy company, announced today that its annual Solutions Series of webinars will start ... industry thought leaders discussing a number of current health and benefits topics, including ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Bellus Medical, ... company’s team of medical experts. In his new role Dr. Dobke will provide physician ... , Dr. Dobke is the Head of Plastic Surgery and Associate Professor of Surgery ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions ... new report from the Frank Hawkins Kenan Institute of Private Enterprise ... academics and policy makers identified concrete solutions at the “What’s Next, America?” conference ...
(Date:1/24/2017)... , ... January 24, 2017 , ... The results from ... for everyone and particularly good news for prostate cancer patients: incidents of cancer is ... According to the report the cancer death rate has dropped from its peak of ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... January 24, 2017 www.Financialbuzz.com ... industries in the United States as ... 2016. In addition, Proposition 64, the California Cannabis Legalization Initiative, ... against on November 8, 2016. This outcome means that individuals ... and to grow a certain amount of cannabis for personal ...
(Date:1/24/2017)... , Jan. 24, 2017   QR Pharma ... company developing novel therapies for the treatment of ... the appointment of four world-class key opinion leaders ... appointments join QR Pharma,s previous roster of impressive ... direction to support the development of the breakthrough ...
(Date:1/24/2017)... 2017 Mezzion has filed a suit for ... alleging that Dr. Reddy,s committed fraud relating to Dr. ... Administration (FDA) cGMP practices, and misrepresenting its compliance to ... to Mezzion that it was compliant with FDA regulations, ... suit also states that Dr. Reddy,s misconduct was the ...
Breaking Medicine Technology: